1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States.

Dalal, Rahul S; Sharma, Puza P; Bains, Kanwal; Pruce, Jordan C; Allegretti, Jessica R

Dalal, Rahul S; Sharma, Puza P; Bains, Kanwal; Pruce, Jordan C; Allegretti, Jessica R.

Afiliação

Dalal RS; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sharma PP; Pfizer Inc, New York, NY, USA.
Bains K; Department of Nutrition, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pruce JC; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Allegretti JR; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Inflamm Bowel Dis ; 2023 Aug 24.

Article em En | MEDLINE | ID: mdl-37619234